Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Review critical factors to watch before investing in Dividend Aristocrats Etf, such as dividend stability, sector concentration, and expense ratios.
25,039 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Uber trades lower after peaking earlier in the year, but quarterly earnings rose sharply as the company leans into au...
Anthropic debuts Claude Tag, a Slack-enabled virtual employee that collaborates across channels to streamline team ta...
CryptoQuant says MicroStrategy’s aggressive Bitcoin purchases risk cash strain in a volatile market, calling on Micro...
Stocks paused after a sharp tech selloff, led by Micron and Intel. Yet one tech name stood out, bucking the trend as ...
An AI-backed forecast tied to Sam Altman’s ChatGPT points to SpaceX stock climbing into the mid-to-high $200s by end-...
Spark and Uniswap are partnering to launch an FX Layer for stablecoins, anchored by a $150 million liquidity migratio...
Bank of America says Micron Technology is trading at a sub-10x forward multiple despite a structural shift toward AI-...
A modest uptick in mortgage rates nudges homebuyers and refinancers to watch inflation, energy prices, and Fed signal...
Three legacy tech giants are pushing new strategies in 2026 as investors weigh durable enterprise moats against consu...
A rapid attribution study links this summer’s extreme European heat to human-caused climate change, showing europe wa...
A prominent on-chain researcher raised alarms about AscendEX withdrawal processing, with users reporting multi-day de...